Molecular Matrix, Inc. welcomed new distributors and distribution partnerships.
Public source
Publisher name
Public post
Most bone graft substitutes are porous. Fewer are engineered to biological specifications: the pore size that vasculature can actually invade, the porosity level that al…
Company
Molecular Matrix, Inc.
We are dedicated to developing an innovative platform technology for tissue regeneration applications.
- Industry
- Medical Equipment Manufacturing
- Location
- Rancho Cordova, US
- Company size
- 11–50 employees
About Molecular Matrix, Inc.
Molecular Matrix, Inc. (MMI) is a tissue regeneration company. Since 2011, we have been dedicated to developing an innovative platform technology for bone regeneration and other life-enhancing applications. For more information about MMI, please visit us at http://www.molecularmatrix.com
See moreDiscover more
Similar signals
Similar public activity from other companies.
Partnerships
BIONX Surgical a division of NEXGEL
BIONX Surgical a division of NEXGEL has been partnered with Sequence LifeScience as the Exclusive U.S. Distributor for the Premiere line of placental-derived Dehydrated Human Amniotic Membrane (DHAM) allografts.
Partnerships
A&M Biomedical Inc.
A&M Biomedical Inc. partnered with Ventric Health to bring innovative medical technology to the people who need it most.
Partnerships
Merakris Therapeutics, Inc.
Merakris Therapeutics, Inc. expanded access to AmnioSurge™ through a strategic distribution partnership with 360 Medical across the United States.
Partnerships
Femasys Inc.
Femasys Inc. partnered with UNC Health to introduce the fertility portfolio including FemaSeed Complete, FemVue, and SpermVue across OB/GYN care locations.
Partnerships
Airway Innovations, Inc.